The awards ceremony also featured insightful keynote addresses, panel discussions, and networking opportunities, providing attendees with valuable insights and opportunities for collaboration.... Apr 27
Glenmark's commitment to providing affordable and effective solutions highlights its role as a leader in diabetes care. As Zita DM becomes a part of ... Oct 19
From business leaders to entrepreneurs, women are setting motivational examples for all of us. On the occasion of International Women’s Day 2022, Medicircle took ... Mar 12
Dr. Aparna Das talks about Jatayu Healthcare Technologies. They have pocket-friendly, speech-based technology platforms using AI, ML, and NLP technologies to transform the ... Jan 11
The story begins in 1977. Saldanha starts a pharmaceutical company named after his two sons - Glenn and Mark. This is the beginning of a global ... Sep 18
Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had ... Sep 16
According to IQVIATM sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales ... Jun 25
... Jun 23
Glenmark has launched Tiotropium Bromide Dry Powder Inhaler (DPI) under the brand name - Tiogiva in UK ... Jun 15
... Feb 23
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
Top ten pharma stocks January 2021... Jan 06
Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals.... Dec 31
The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
... Dec 23
Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules... Dec 21
According to IQVIA sales data for the 12 month period ending October 2020, the Inlyta Tablets market achieved annual sales of approximately $518.8 million*.... Dec 01
Glenmark to launch Ryaltris, their global anti-allergy brand, in Russia and other CIS countries after the divestment ... Nov 30
DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top-ranked companies in terms of Corporate ... Nov 26
The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
Glenmark has been granted final approval by the U.S. FDA for Tacrolimus Capsules USP, the generic version of Prograf Capsules, of Astellas Pharm US, ... Nov 11
Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
Glenmark received approval from ANDA for Sirolimus Tablets, a generic version of Rapamune Tablets... Oct 19
Glenmark being a leader in the area of respiratory has been amongst the first to launch the branded generic version for the treatment of Pulmonary ... Oct 14
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera... Oct 07
-Advertisements-
Saturday, June 15, 2024
